Top Biotech Companies (3,709)
Helping Make Research Possible We are helping make research possible by supplying scientists worldwide with the assay kits, antibodies, proteins, and biochemicals to advance their research. We know the scientific community needs more than our products, so our 100 in-house scientists, the same who design and develop our products, connect with researchers to answer questions, provide resources, and offer contract research...
The Lauridsen Group (LGI) is a privately held, global group of six independent companies focused on discovering and manufacturing products that advance health and nutrition. Its businesses include APC, BHJ, Boyer Valley Company, Essentia Protein Solutions, Proliant Dairy Ingredients, and Proliant Health & Biologicals, supplying functional proteins, food ingredients, and biological solutions for human, animal, and industrial applications across international...
Excel Scientific Inc. designs and manufactures microplate sealing films, foils, and custom laminate constructions for life-science and diagnostic applications. Its medical-grade products support PCR, qPCR, ELISA, cell culture, sample storage, point-of-care disposables, and microfluidic components. The company serves pharmaceutical and biotechnology firms, diagnostic OEMs, clinical laboratories, research organizations, and academic institutions, producing its solutions in the United States under an...
AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases. AIRNA’s experienced team is aiming to advance a pipeline of RNA editing therapeutics driven by its powerful and flexible RNA editing platform, RESTORE+.
DM Clinical Research is a multi-therapeutic network of clinical trial investigator sites headquartered in Houston, Texas. Founded in 2006, the company connects patients with trusted physicians to conduct cutting-edge research focused on quality and compassion, aiming to deliver advanced, preventative medicine to underserved communities. They operate a national network of dedicated research centers and physician-embedded sites throughout the United States.
Galatea Bio is an innovative, venture-backed biotechnology company dedicated to advancing precision health for all. The company leverages world-class ancestry algorithms to better understand underserved Latin American populations while maintaining a strong commitment to ethical research. It partners with pharmaceutical and life sciences organizations to design and execute projects that utilize human genetic diversity to solve acute problems in biomedicine.
With the power to skillfully write meaningful DNA sequences, we embark on a new era where precise control over biology and the manipulation of matter in our environment is possible. Constructive Biology is a spin out from the laboratory of Prof. Jason Chin at the MRC Laboratory of Molecular Biology in Cambridge. Our platform allow us to fundamentally reprogram the...
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and autoimmune diseases.
Cullinan Oncology is dedicated to creating new standards of care for patients with cancer. We innovate without borders to find the most promising clinic-ready cancer therapies, whether from our own discovery efforts or through exceptional engagement with our academic and industry partners. Anchored in a deep understanding of immuno-oncology and translational cancer medicine, we leverage our scientific excellence in small molecules and...
Vorticity Inc. is redefining how the world tackles complex scientific and engineering problems. We design and build the full technology stack — from custom silicon to cloud-accessible software platforms — to accelerate physics-based simulation and data-intensive computation across industries. Our mission is to dramatically reduce the time and cost of scientific discovery by re-thinking every layer of the compute stack. We...
Vorticity Inc.'s Top Stability & Growth Strengths
Strategic Partnerships: The company lists partnerships with AWS, Google X, Stanford University, California Institute of Technology, and Shell, signaling access to customers and co-development in target sectors. These relationships suggest traction pathways in energy, life sciences, and aerospace.
Innovation-Driven Growth: The firm is developing a novel silicon architecture (Pyrite9 Scientific Processing Unit) and vertically integrated software, with claims of order-of-magnitude speed improvements and a geophysics inversion portal demonstrating recent application impact. Feedback suggests continued R&D momentum with plans to release faster custom chips and platforms across molecular dynamics, geophysics, and finance.
Product Line Growth: Offerings have expanded to include Asclepius (molecular dynamics), Astrape (geophysics), Rhea (full waveform inversion), and Plutus (options pricing and VaR), alongside a cloud-native MD platform. This breadth indicates active productization across multiple industries.
For 85 years, PerkinElmer has pushed the boundaries of science from food to health to the environment. We’ve always pursued science with a clear purpose – to help our customers achieve theirs. Our expert team brings technology and intangibles, like creativity, empathy, diligence, and a spirit of collaboration, in equal measure, to fulfill our customers’ desire to work better, innovate...
PerkinElmer's Top Stability & Growth Strengths
Strong Market Position & Advantage: Colleagues are often seen as operating from a top-tier competitive position in applied, food, and environmental analytical markets, including a significant presence in food testing and leadership in multivendor lab services via OneSource. The large global installed base and asset footprint are portrayed as reinforcing defensibility and ongoing demand for services and support.
Innovation-Driven Growth: Colleagues are often seen as sustaining relevance through ongoing product launches and upgrades such as digital PCR systems, updated LIMS software, and new analytical platforms aimed at emerging needs like PFAS detection and battery applications. The continued cadence of new instruments and workflow solutions is positioned as a key growth lever alongside services and consumables.
Investor Backing & Capital Strength: Colleagues are often seen as supported by private-equity ownership under New Mountain Capital and described with a substantial valuation, suggesting access to capital and an explicit mandate to scale. Recent acquisitions (e.g., Covaris and Project Farma) are framed as capability-building moves consistent with a funded expansion strategy.
Forge Biologics is a gene therapy contract development and manufacturing organization (CDMO) that helps bring transformative treatments from concept to patients. It provides scalable plasmid and AAV manufacturing, process and analytical development, cGMP production, fill-finish, quality, stability, and regulatory support. The company operates the Hearth, a large Columbus, Ohio facility designed to accelerate development of therapies for genetic diseases more...
ENABLING NEUROTECHNOLOGY Paradromics’ Brain-Computer Interface (BCI) platform records brain activity at the highest possible resolution: the individual neuron. Our AI algorithms decode this massive amount of brain-data, enabling the seamless translation of thought into treatments. THE MISSION Data-driven BCI-based technologies for brain health Our technology will help millions with unmet medical needs suffering from paralysis and movement disorders to chronic pain, addiction, depression and...
Ivy Fertility is a globally recognized network of fertility centers that unites top-performing reproductive clinics to provide patients with extraordinary medical care for their family-building needs. They specialize in advanced reproductive technologies, in-vitro fertilization, and third-party reproduction, combining expertise and innovation to deliver personalized fertility services with a commitment to patient success.
Biomed Global is a leading total solution provider in the biomedical and life sciences industry, operating across Southeast Asia. The company provides a holistic range of innovative medical solutions and cutting-edge biomedical technologies spanning research, development, and clinical applications. Its mission is to advance healthcare standards and facilitate medical breakthroughs by bringing together leading-edge medical solutions and expert support to...
Deeply rooted in community oncology centers globally, the START Center for Cancer Research ('START') provides patients with access to specialized Phase 1 clinical trials for novel anti-cancer agents. With research sites in the United States and in Spain, Portugal, and Ireland, START’s clinical trial sites have conducted more than 1,500 early phase clinical trials, including for 50 therapies that have...
Energy to Healthcare Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical...
Ashfield Advisory is a business unit that provides integrated advisory and consulting services to the healthcare industry, leveraging an ecosystem of specialized businesses for insight, strategy, and action.
With 30+ years of experience, 28+ locations, and 2,000+ clinical studies conducted, Elite Clinical Network (ECN) is a trusted leader in clinical research. Our dedicated network of research sites is built on personalized service, investigator diversity, and rigorous quality processes to ensure excellence in every study. Backed by a professional corporate management team, we partner with top physicians across diverse specialties...
Ascendis Pharma is applying its innovative TransCon technologies to build a leading, fully integrated biopharmaceutical company focused on making a meaningful difference in patients’ lives. Guided by its core values of patients, science and passion, the company utilizes its TransCon technologies to create new and potentially best-in-class therapies. Ascendis Pharma currently has a pipeline of three independent endocrinology rare disease product...
